Clinical Trial Update: Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial comparing hypofractionated versus conventionally fractionated concurrent chemoradiation therapy for unresectable stage III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Unresectable Stage III Non-small-cell Lung Cancer | Phase 3 | Status: UNKNOWN